Archive - February 2018
FDA nod for Vertex’s improved CF combo, Symdeko, opens $200M door this year
Vaccines Can Stem Poverty, Not Just Disease, Study Suggests
Five states, five different patterns for healthcare spending—and no easy path to lower costs
Missouri hospitals win a round in legal battle over CMS’ DSH clawback
Product Focus: Single-Use Technologies
Celgene ex-CEO Hugin launches Senate run in New Jersey amid protest from drug-price critics
ADC specialist ImmunoGen closing Massachusetts plant, cutting 20 jobs
Walgreens, AmerisourceBergen deal unlikely to cut drug prices